EWTX - Edgewise Therapeutics, Inc.

Over the past 90 days, insiders at Edgewise Therapeutics, Inc. (EWTX) have been net sellers, shedding 43,429 shares worth roughly $1.9M on balance.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Kevin Koch	52.5K	$1.98M	-
Other	Behrad Derakhshan	31.8K	$1.20M	-
Other	Alan J Russell	31.5K	$1.19M	-
Dir	Jonathan C Fox	25.1K	$947.3K	-
Dir	Badreddin Edris	19.8K	$746.8K	-

Buys and sells only

10 filings · page 8

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 10, 2022	John R Moore	General Counsel	Sale+OE	27,306	$6.44	$175,878.36	-90.1%	+102.3%	+61.6%
Jun 7, 2022	John R Moore	General Counsel	Sale+OE	47,287	$6.26	$295,984.99	-94.0%	+56.8%	+47.8%
May 18, 2022	Orbimed Advisors LLC68	Director, 10% Owner	Buy	138,000	$7.21	$994,980.00	+1.0%	+51.1%	+28.2%
May 18, 2022	Peter A. Thompson64	Director, 10% Owner	Buy	138,000	$7.21	$994,980.00	+1.0%	+51.1%	+28.2%
May 16, 2022	John R Moore	General Counsel	Sell	10,800	$7.42	$80,145.72	-78.3%	+47.6%	+28.4%
Nov 15, 2021	Alan J Russell74	Chief Scientific Officer	Sell	479	$19.11	$9,155.40	-100%	-41.5%	-46.5%
Nov 12, 2021	Alan J Russell74	Chief Scientific Officer	Sell	69,740	$19.91	$1,388,787.60	-99.3%	-34.5%	-44.2%
Nov 8, 2021	Alan J Russell74	Chief Scientific Officer	Sell	29,451	$19.82	$583,823.46	-29.5%	-37.7%	-52.2%
Nov 3, 2021	Alan J Russell74	Chief Scientific Officer	Sell	44,172	$17.88	$789,908.90	-30.7%	-28.9%	-47.9%
Oct 15, 2021	Alan J Russell74	Chief Scientific Officer	Sell	7,182	$18.17	$130,482.95	-4.8%	-2.7%	-41.3%